Patent intelligence · US
US 7183267
β-lactamase inhibitors and methods of use thereof
β-lactamase inhibitors and methods of use thereof
Patent details — US 7183267
- Jurisdiction
- US
- Status
- granted
- Grant date
- Feb 27, 2007
- Expiration
- Feb 22, 2027
- Applicant
- Fulcrum Pharmaceuticals Inc.
- Claims
- 21
- CPC classes
- A61K, A61K31/381, A61P, A61P31/04
Quick answer
US 7183267 (β-lactamase inhibitors and methods of use thereof) is held by Fulcrum Pharmaceuticals Inc.. Status: granted. Granted Feb 27, 2007. Expires Feb 22, 2027 (1 year remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Fulcrum Pharmaceuticals Inc.
- Grant date
- Expiration
- Claims
- 21
- CPC classes
- A61K, A61K31/381, A61P, A61P31/04, A61P43/00
More from Fulcrum Pharmaceuticals Inc.
Related pharmaceutical patents in our USPTO index.
-
US 12109198
Macrocyclic azolopyridine derivatives as EED and PRC2 modulators
granted -
US 11819554
Compositions and methods for modulating FMR1 expression
granted -
US 11590111
Macrocyclic azolopyridine derivatives as EED and PRC2 modulators
granted -
US 11479770
Use of p38 inhibitors to reduce expression of DUX4
granted -
US 11291659
P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD
granted -
US 10973805
Macrocyclic azolopyridine derivatives as EED and PRC2 modulators
granted -
US 10537560
P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD
granted -
US 10342786
P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD
granted
Frequently asked questions
What is US patent 7183267?
US 7183267 (β-lactamase inhibitors and methods of use thereof) is held by Fulcrum Pharmaceuticals Inc.. Status: granted. Granted Feb 27, 2007. Expires Feb 22, 2027 (1 year remaining) — relevant for patent-cliff and LOE planning.
Who owns US 7183267?
Fulcrum Pharmaceuticals Inc. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 11 pharmaceutical patents for this assignee.
When does US 7183267 expire?
Our index shows an expiration date of Feb 22, 2027 (1 year from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.